Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
07/02/2008 | EP1451181B1 Dimeric compounds and their use as anti-viral agents |
07/02/2008 | EP1446022B1 Oilseed processing |
07/02/2008 | EP1427436B1 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
07/02/2008 | EP1392731B1 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
07/02/2008 | EP1366455B1 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity |
07/02/2008 | EP1250148B2 Use of fsh for treating infertility |
07/02/2008 | EP1169347B1 Compounds and methods for therapy and diagnosis of lung cancer |
07/02/2008 | EP1128838B1 Extracellular matrix containing gdf-5 for inducing or enhancing chondrogenesis |
07/02/2008 | EP1119349B1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
07/02/2008 | EP0966300B1 Treatment of rheumatoid arthritis with antibody anti ifn gamma |
07/02/2008 | EP0896055B1 Apoptosis inducing protein and gene encoding the same |
07/02/2008 | CN101213214A Single domain VHH antibodies against von willebrand factor |
07/02/2008 | CN101213210A Polypeptide, vaccine and use thereof |
07/02/2008 | CN101213209A Oxyntomodulin analogues and their effects on feeding behaviour |
07/02/2008 | CN101212985A Kinin antagonists for treating bladder dysfunction |
07/02/2008 | CN101212982A FK228 derivates as HDAC inhibitors |
07/02/2008 | CN101212970A Combination of HCV protease inhibitors with a surfactant |
07/02/2008 | CN101210261A Method for preparing sipunculid polypeptide and application thereof |
07/02/2008 | CN101210244A Neutrokine-alpha and Neutrokine-alpha splice variants |
07/02/2008 | CN101210239A Double-functional molecule for dissolving thrombus and inhibiting blood platelet aggregate and use thereof |
07/02/2008 | CN101210051A Anti-VEGF antibodies |
07/02/2008 | CN101210050A Anti-vegf antibodies |
07/02/2008 | CN101210047A Active peptide and application thereof |
07/02/2008 | CN101210046A Antifungal protein and usage thereof |
07/02/2008 | CN101210044A Polypeptide and application thereof |
07/02/2008 | CN101209347A Pharmaceutical compositions of fibrinolytic agent |
07/02/2008 | CN101209346A Medicament for treating dyspepsia and preparation thereof |
07/02/2008 | CN101209345A Animal genetic engineering interferon alpha and gamma composite preparations and production method and clinical application thereof |
07/02/2008 | CN101209344A Application of hyperosmotic fluid composition in preparing medicament for improving wound healing |
07/02/2008 | CN101209343A Preparations for treating mastitis of cow and preparation thereof |
07/02/2008 | CN101209342A Application of helianthus tuberosus agglutinin in preparing medicine for treating constipation and delaying stomach and intestine retrogradation |
07/02/2008 | CN101209242A Recombination human epidermal growth factor spray and preparation method thereof |
07/02/2008 | CN100398661C Casein hydrolyzate, process for producing the same and use thereof |
07/02/2008 | CN100398653C Novel streptococcus antigens |
07/02/2008 | CN100398650C Recombinant human II type collagen functional polypeptide C II 250-270 and its preparation method and application |
07/02/2008 | CN100398558C Active segment of HER2/neu with Herstatin interaction, coding gene and application thereof |
07/02/2008 | CN100398557C Polypeptide for inhibition of angiogenesis and method for preparing same and use thereof |
07/02/2008 | CN100398555C Protease inhibitors for coronaviruses and SARS-COV and the use thereof |
07/02/2008 | CN100398551C Novel isoforms of vascular endothelial cell growth inhibitor |
07/02/2008 | CN100398153C Combined pharmaceutical application of antiangiogenic drugs and photosensitizers |
07/02/2008 | CN100398152C Novel human beta 2 integrin alpha subunit |
07/02/2008 | CN100398149C Application of human sDR5 protein as medicine to treat virus hepatitis B |
07/02/2008 | CN100398148C Nutrient and healthy capsule of active ass hide |
07/01/2008 | US7393994 Animal model for use in the diagnosis and treatment of nervous system disorders |
07/01/2008 | US7393950 To inhibit the growth of tumor cells in mammals |
07/01/2008 | US7393944 Lymphocytes; transcription factors; interferons |
07/01/2008 | US7393942 Nucleic acids encoding mutant forms of Fas ligand |
07/01/2008 | US7393938 Use of lipid conjugates in the treatment of diseases |
07/01/2008 | US7393934 Human G-protein chemokine receptor (CCR5) HDGNR10 |
07/01/2008 | US7393933 Hepatitis B monoclonal antibodies |
07/01/2008 | US7393932 Endothelial cell expression patterns |
07/01/2008 | US7393931 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
07/01/2008 | US7393929 Inhibitors of cellulolytic, xylanolytic and β-glucanolytic enzymes |
07/01/2008 | US7393928 Recombinant gelatins |
07/01/2008 | US7393927 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
07/01/2008 | US7393925 structural modification alters the biological persistence, preferably the biological half-life |
07/01/2008 | US7393920 Deprotecting amino acid linked to solid phase resin by admixing with solution in transparent vessel while irradiating with microwaves, coupling/activating/hybridizing amino acids, then cleaving |
07/01/2008 | US7393919 Peptides, derivatives and analogs thereof, and methods of using same |
07/01/2008 | US7393918 Protein binding miniature proteins and uses thereof |
07/01/2008 | US7393917 PRO1482 polypeptides |
07/01/2008 | US7393849 N-[4-Amidinobenzoyl]-N-[3-phenoxybenzyl]-3-(4-biphenyl)-alanyl-glycyl-amide; anticarcinogenic, antidiabetic, anticholesterol agent, cardiovascular disorders, osteoporosis |
07/01/2008 | US7393839 Crystalline forms A and B of Levovirin valinate hydrochloride (2-(S)-amino-3-methyl-butyric acid 5S-(3-carbamoyl-[1,2,4]triazol-1-yl)-3R,4S-dihydroxy-tetrahydrofuran-2S-yl methyl ester, monohydrochloride): hemihydrate; Hepatitis C virus; physical and chemical stability; solubility and flowability |
07/01/2008 | US7393837 Method for treating metabolic bone disease such as osteomalacia and osteoporosis in a patient by administering a compound that modulates phosphate regulating endopeptidase homolog (PEX) expression and/or PEX enzymatic activity |
07/01/2008 | US7393835 Peptide inhibitors of protein kinase C |
07/01/2008 | US7393834 LHRH-antagonists in the treatment of fertility disorders |
07/01/2008 | US7393833 inducing hemostasis or thrombosis in a human patient have a bleeding disorder by providing a chimeric protein comprising Annexin V and a soluble tissue factor domain |
07/01/2008 | US7393832 Nucleotide sequences coding membrane proteiin receptor for identifying modulators for prevention and treatment of nervous system, vision and cell proliferative disorders; wound healing agents; |
07/01/2008 | US7393831 prophylactic and therapeutic vaccination directed against the hepatitis C virus |
07/01/2008 | US7393830 Prolactin induced increase in neural stem cell numbers |
07/01/2008 | US7393829 Peptide that inhibits stimulated endothelial cell proliferation |
07/01/2008 | US7393827 biological response modifier (lisofylline) and a beta -cell growth factor (exendin-4 or exenatide) in admixture with a pharmaceutically acceptable carrier; for treating Type 1 diabetes, autoimmune diabetes, or insulin dependent diabetes mellitus |
07/01/2008 | US7393825 Restoring balance in vascular tone without systemic effect in normal vasculature; administration of minimal amounts of nitric oxide donors and/or guanyl cyclase activators |
07/01/2008 | US7393824 Methods of peptide preparation |
07/01/2008 | US7393823 isolated polypeptide, glycosylated polypeptide and monoclonal antibody and their combinations; binds to the extracellular domain of EGF receptor |
07/01/2008 | US7393684 Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies |
07/01/2008 | US7393682 Polynucleotides encoding promyostatin polypeptides |
07/01/2008 | US7393681 System and method for electroporating a sample |
07/01/2008 | US7393672 DNA coding for endo-β-galactosidase |
07/01/2008 | US7393666 Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis |
07/01/2008 | US7393662 Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
07/01/2008 | US7393661 Nucleic acids encoding OBG3 polypeptides |
07/01/2008 | US7393660 Polypeptide of given sequence; transforming or transfecting cell with expression vector; inhibits tumor necrosis factor release; anti-inflammatory |
07/01/2008 | US7393657 Diagnosis and treatment of cancer: I |
07/01/2008 | US7393649 Using protrein oxidation as diagnostic tool in detection of arthritic, cell proliferative, nervous system and autoimmue disorders |
07/01/2008 | US7393540 Therapeutic peptide for prevention of microorganismal infections; enzyme inhibitors; RNA inteference; antisense agents |
07/01/2008 | US7393539 Therapeutic agent for prevention and treatment of bacterial infection; bactericides; genetic vaccines; immunotherapy |
07/01/2008 | US7393538 treating obsessions and compulsions, in particular skin picking, by local administration of Clostridial toxin; low dose, intramuscular administration of botulinum toxin |
07/01/2008 | US7393537 Botulinum toxin for treatment of obsessive compulsive finger biting disorder |
07/01/2008 | US7393536 Nucleotide sequences coding streptococcus capsular polysaccharide antigens for use in diagnosis and prevention of infections in mammals; veterinary medicine |
07/01/2008 | US7393534 Compositions and methods for immunotherapy of cancer and infectious diseases |
07/01/2008 | US7393530 IL-1-like cytokine antibodies |
07/01/2008 | US7393529 Antiallergens |
07/01/2008 | US7393528 Applying an aqueous mixture comprising protease, surfactants, detergent builders, for exterminating pests |
07/01/2008 | US7393526 Systemic gene delivery vehicles for the treatment of tumors |
07/01/2008 | US7393523 Peptides for active anti-cytokine immunization |
07/01/2008 | US7393437 Reconstitution of three-dimensional collagen matrices from collagen monomer solution and crosslinking the matrix with a light source in the presence of a photosensitizing reagent; tissue engineering |
06/26/2008 | WO2008077109A1 Methods of treating alzheimer's disease |
06/26/2008 | WO2008077077A2 Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors |
06/26/2008 | WO2008076824A2 Therapeutic and diagnostic peptides |
06/26/2008 | WO2008076819A2 Human growth hormone formulations |